187 related articles for article (PubMed ID: 12812348)
1. Frequency, severity, and costs of adverse reactions following mass treatment for lymphatic filariasis using diethylcarbamazine and albendazole in Leogane, Haiti, 2000.
McLaughlin SI; Radday J; Michel MC; Addiss DG; Beach MJ; Lammie PJ; Lammie J; Rheingans R; Lafontant J
Am J Trop Med Hyg; 2003 May; 68(5):568-73. PubMed ID: 12812348
[TBL] [Abstract][Full Text] [Related]
2. The Leogane, Haiti demonstration project: decreased microfilaremia and program costs after three years of mass drug administration.
de Rochars MB; Kanjilal S; Direny AN; Radday J; Lafontant JG; Mathieu E; Rheingans RD; Haddix AC; Streit TG; Beach MJ; Addiss DG; Lammie PJ
Am J Trop Med Hyg; 2005 Nov; 73(5):888-94. PubMed ID: 16282299
[TBL] [Abstract][Full Text] [Related]
3. Treatment of Brugia timori and Wuchereria bancrofti infections in Indonesia using DEC or a combination of DEC and albendazole: adverse reactions and short-term effects on microfilariae.
Supali T; Ismid IS; Rückert P; Fischer P
Trop Med Int Health; 2002 Oct; 7(10):894-901. PubMed ID: 12358626
[TBL] [Abstract][Full Text] [Related]
4. Endpoints for lymphatic filariasis programs.
Grady CA; de Rochars MB; Direny AN; Orelus JN; Wendt J; Radday J; Mathieu E; Roberts JM; Streit TG; Addiss DG; Lammie PJ
Emerg Infect Dis; 2007 Apr; 13(4):608-10. PubMed ID: 17553278
[TBL] [Abstract][Full Text] [Related]
5. Doxycycline treatment of Brugia malayi-infected persons reduces microfilaremia and adverse reactions after diethylcarbamazine and albendazole treatment.
Supali T; Djuardi Y; Pfarr KM; Wibowo H; Taylor MJ; Hoerauf A; Houwing-Duistermaat JJ; Yazdanbakhsh M; Sartono E
Clin Infect Dis; 2008 May; 46(9):1385-93. PubMed ID: 18419441
[TBL] [Abstract][Full Text] [Related]
6. Pharmacovigilance through consumer feedback (reporting) in the mass treatment of lymphatic filariasis using diethylcarbamazine and albendazole in two districts of Sri Lanka.
Gunawardena S; Sri Ranganathan S; Fernandopulle R
Trop Med Int Health; 2008 Sep; 13(9):1153-8. PubMed ID: 18631319
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and tolerability of treatment with single doses of diethylcarbamazine (DEC) and DEC plus albendazole (ABZ) for three consecutive years in lymphatic filariasis: a field study in India.
Kshirsagar NA; Gogtay NJ; Garg BS; Deshmukh PR; Rajgor DD; Kadam VS; Thakur PA; Gupta A; Ingole NS; Lazdins-Helds JK
Parasitol Res; 2017 Oct; 116(10):2683-2694. PubMed ID: 28785847
[TBL] [Abstract][Full Text] [Related]
8. Adverse reactions following mass drug administration during the Programme to Eliminate Lymphatic Filariasis in Orissa State, India.
Babu BV; Rath K; Kerketta AS; Swain BK; Mishra S; Kar SK
Trans R Soc Trop Med Hyg; 2006 May; 100(5):464-9. PubMed ID: 16288792
[TBL] [Abstract][Full Text] [Related]
9. Comparison of methods for estimating drug coverage for filariasis elimination, Leogane Commune, Haiti.
Mathieu E; Deming M; Lammie PJ; McLaughlin SI; Beach MJ; Deodat DJ; Addiss DG
Trans R Soc Trop Med Hyg; 2003; 97(5):501-5. PubMed ID: 15307410
[TBL] [Abstract][Full Text] [Related]
10. Children and adolescents infected with Wuchereria bancrofti in Greater Recife, Brazil: a randomized, year-long clinical trial of single treatments with diethylcarbamazine or diethylcarbamazine-albendazole.
Rizzo JA; Belo C; Lins R; Dreyer G
Ann Trop Med Parasitol; 2007 Jul; 101(5):423-33. PubMed ID: 17550648
[TBL] [Abstract][Full Text] [Related]
11. Costs of integrated mass drug administration for neglected tropical diseases in Haiti.
Goldman AS; Brady MA; Direny A; Desir L; Oscard R; Vely JF; Linehan M; Baker M
Am J Trop Med Hyg; 2011 Nov; 85(5):826-33. PubMed ID: 22049035
[TBL] [Abstract][Full Text] [Related]
12. Mass drug administration to treat lymphatic filariasis.
Ravindran B
Lancet; 2002 Jun; 359(9321):1948. PubMed ID: 12057582
[No Abstract] [Full Text] [Related]
13. National mass drug administration costs for lymphatic filariasis elimination.
Goldman AS; Guisinger VH; Aikins M; Amarillo ML; Belizario VY; Garshong B; Gyapong J; Kabali C; Kamal HA; Kanjilal S; Kyelem D; Lizardo J; Malecela M; Mubyazi G; Nitièma PA; Ramzy RM; Streit TG; Wallace A; Brady MA; Rheingans R; Ottesen EA; Haddix AC
PLoS Negl Trop Dis; 2007 Oct; 1(1):e67. PubMed ID: 17989784
[TBL] [Abstract][Full Text] [Related]
14. Efficacy, Safety, and Pharmacokinetics of Coadministered Diethylcarbamazine, Albendazole, and Ivermectin for Treatment of Bancroftian Filariasis.
Thomsen EK; Sanuku N; Baea M; Satofan S; Maki E; Lombore B; Schmidt MS; Siba PM; Weil GJ; Kazura JW; Fleckenstein LL; King CL
Clin Infect Dis; 2016 Feb; 62(3):334-341. PubMed ID: 26486704
[TBL] [Abstract][Full Text] [Related]
15. Adverse reactions of 300 MG diethylcarbamazine, and in a combination of 400 MG albendazole, for a mass annual single dose treatment, in migrant workers in Phang Nga province.
Yongyuth P; Koyadun S; Jaturabundit N; Jariyahuttakij W; Bhumiratana A
J Med Assoc Thai; 2007 Mar; 90(3):552-63. PubMed ID: 17427535
[TBL] [Abstract][Full Text] [Related]
16. An analysis of the safety of the single dose, two drug regimens used in programmes to eliminate lymphatic filariasis.
Horton J; Witt C; Ottesen EA; Lazdins JK; Addiss DG; Awadzi K; Beach MJ; Belizario VY; Dunyo SK; Espinel M; Gyapong JO; Hossain M; Ismail MM; Jayakody RL; Lammie PJ; Makunde W; Richard-Lenoble D; Selve B; Shenoy RK; Simonsen PE; Wamae CN; Weerasooriya MV
Parasitology; 2000; 121 Suppl():S147-60. PubMed ID: 11386686
[TBL] [Abstract][Full Text] [Related]
17. Identifying co-endemic areas for major filarial infections in sub-Saharan Africa: seeking synergies and preventing severe adverse events during mass drug administration campaigns.
Cano J; Basáñez MG; O'Hanlon SJ; Tekle AH; Wanji S; Zouré HG; Rebollo MP; Pullan RL
Parasit Vectors; 2018 Jan; 11(1):70. PubMed ID: 29382363
[TBL] [Abstract][Full Text] [Related]
18. Using knowledge, attitudes and practice (KAP) surveys on lymphatic filariasis to prepare a health promotion campaign for mass drug administration in Alor District, Indonesia.
Krentel A; Fischer P; Manoempil P; Supali T; Servais G; Rückert P
Trop Med Int Health; 2006 Nov; 11(11):1731-40. PubMed ID: 17054754
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of effectiveness of diethylcarbamazine/albendazole combination in reduction of Wuchereria bancrofti infection using multiple infection parameters.
Wamae CN; Njenga SM; Ngugi BM; Mbui J; Njaanake HK
Acta Trop; 2011 Sep; 120 Suppl 1():S33-8. PubMed ID: 20933491
[TBL] [Abstract][Full Text] [Related]
20. Safety, tolerability, efficacy and plasma concentrations of diethylcarbamazine and albendazole co-administration in a field study in an area endemic for lymphatic filariasis in India.
Kshirsagar NA; Gogtay NJ; Garg BS; Deshmukh PR; Rajgor DD; Kadam VS; Kirodian BG; Ingole NS; Mehendale AM; Fleckenstein L; Karbwang J; Lazdins-Helds JK
Trans R Soc Trop Med Hyg; 2004 Apr; 98(4):205-17. PubMed ID: 15049459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
